Advertisement

Some recent developments in the physiology of the thyroid gland

  • John B. Stanbury
Conference paper
Part of the Ergebnisse der Physiologie, biologischen Chemie und experimentellen Pharmakologie book series (ERGEBPHYSIOL, volume 65)

Keywords

Thyroid Hormone Thyroid Gland Adenyl Cyclase Glucose Oxidation Thyroid Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams, D. D.: The presence of an abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients. J. clin. Endocr. 18, 699–712 (1958).PubMedGoogle Scholar
  2. Adams, D. D.: A comparison of the rates at which thyrotrophin and the human abnormal thyroid stimulator disappear from the circulating blood of the rat. Endocrinology 66, 658–664 (1960).PubMedGoogle Scholar
  3. Adams, D. D., Couchman, K., Kilpatrick, J. A.: Lack of response to TSH injections in euthyroid patients with high LATS levels. J. clin. Endocr. 29, 1502–1503 (1969).PubMedGoogle Scholar
  4. Adams, D. D., Kennedy, T. H., Purves, H. D., Sirett, N. E.: Failure of TSH antisera to neutralize long-acting thyroid stimulator. Endocrinology 70, 801–805 (1962).PubMedGoogle Scholar
  5. Ahn, C. S., Athans, J. C., Rosenberg, I. N.: Stimulation of thyroid hormone secretion by dibutyryl cyclic-AMP. Endocrinology 85, 224–230 (1969).PubMedGoogle Scholar
  6. Ahn, C. S., Rosenberg, I. N.: Proteolysis in thyroid slices: Effects of TSH, dibutyryl cyclic 3′,5′-AMP and prostaglandin E1. Endocrinology 86, 870–873 (1970a).PubMedGoogle Scholar
  7. Ahn, C. S., Rosenberg, I. N.: Iodine metabolism in thyroid slices: Effects of TSH dibutyryl cyclic 3′,5′-AMP, NaF and prostaglandin E1. Endocrinology 86, 396–405 (1970b).PubMedGoogle Scholar
  8. Alexander, N. M., Burrow, G. N.: Thyroxine biosynthesis in human goitrous cretinism. J. clin. Endocr. 30, 308–315 (1970).PubMedGoogle Scholar
  9. Averill, R. L. W.: Responses to thyrotropin-releasing factor (TRF) by intrapituitary infusion of hypothalamic extracts. Endocrinology 84, 514–519 (1969a).PubMedGoogle Scholar
  10. Averill, R. L. W.: Depression of thyrotropin releasing factor induction of thyrotropin release by thyroxine in small doses. Endocrinology 85, 67–71 (1969b).PubMedGoogle Scholar
  11. Baugh, C. M., Krumdieck, C. L., Hershman, J. M., Pittman, J. A., Jr.: Synthesis and biological activity of thyrotropin-releasing hormone. Endocrinology 87, 1015 (1970).PubMedGoogle Scholar
  12. Beall, G. N., Daniel, P. M., Pratt, O. E., Solomon, D. H.: Effects of immunization of baboons with human thyroid tissue. J. clin. Endocr. 29, 1460–1469 (1969b).PubMedGoogle Scholar
  13. Beall, G., Doniach, D., Roitt, I., El Kabir, D.: Inhibition of the long-acting thyroid stimulator (LATS) by soluble thyroid fractions. J. Lab. clin. Med. 73, 988–999 (1969a).PubMedGoogle Scholar
  14. Bowers, C. Y., Lee, K. L., Schally, A. V.: Effect of actinomycin D on hormones that control the release of thyrotropin from the anterior pituitary glands of mice. Endocrinology 82, 303–310 (1968b).PubMedGoogle Scholar
  15. Bowers, C. Y., Lee, K. L., Schally, A. V.: A study on the interaction of the thyrotropin-releasing factor and L-triiodothyronine: Effects of puromycin and cycloheximide. Endocrinology 82, 75–82 (1968c).PubMedGoogle Scholar
  16. Bowers, C. Y., Schally, A. V., Enzmann, F., Boler, J., Folkers, K.: Porcine thyrotropin releasing hormone is (pyro)glu-his-pro(NH2). Endocrinology 86, 1143–1153 (1970).PubMedGoogle Scholar
  17. Bowers, C. Y., Schally, A. V., Hawley, W. D., Gual, C., Parlow, A.: Effect of thyrotropin-releasing factor in man. J. clin. Endocr. 28, 978–982 (1968a).PubMedGoogle Scholar
  18. Burgus, R., Dunn, T. F., Desiderio, D. M., Ward, D. N., Vale, W., Guillemin, R., Felix, A. M., Gillessen, D., Studer, R. O.: Biological activity of synthetic polypeptide derivatives related to the structure of hypothalamic TRF. Endocrinology 86, 573–582 (1970).PubMedGoogle Scholar
  19. Burke, G.: The long-acting thyroid stimulator of Graves' disease. Amer. J. Med. 45, 435–450 (1968a).PubMedGoogle Scholar
  20. Burke, G.: On the competitive interaction of long-acting thyroid stimulator and thyrotropin in vivo. J. clin. Endocr. 28, 286–293 (1968b).PubMedGoogle Scholar
  21. Burke, G.: Effects of adrenergic blocking agents on basal and stimulated thyroid function. Metabolism 18, 961–967 (1969a).PubMedGoogle Scholar
  22. Burke, G.: Failure of theophylline to potentiate stimulated thyroidal glucose oxidation and phospholipogenesis. Endocrinology 84, 1055–1062 (1969b).PubMedGoogle Scholar
  23. Burke, G.: Comparative effects of thyrotropin and long-acting thyroid stimulator on thyroidal intermediary metabolism: Relationship to pyridine nucleotide levels. Metabolism 18, 132–140 (1969c).PubMedGoogle Scholar
  24. Burke, G.: The cell membrane: A common site of action of thyrotropin (TSH) and long-acting thyroid stimulator (LATS). Metabolism 18, 720–729 (1969d).PubMedGoogle Scholar
  25. Burke, G.: Comparison of thyrotropin and sodium fluoride effects on thyroid adenyl cyclase. Endocrinology 86, 346–352 (1970a).PubMedGoogle Scholar
  26. Burke, G.: On the role of adenyl cyclase activation and endocytosis in thyroid slice metabolism. Endocrinology 86, 353–359 (1970b).PubMedGoogle Scholar
  27. Burke, G., Silverstein, G. E.: Hypothyroidism after treatment with sodium iodide I-131. J. Amer. med. Ass. 210, 1051–1058 (1969).Google Scholar
  28. Buttfield, I. H., Black, M. L., Hoffman, M. J., Mason, E. K., Hetzel, B. S.: Correction of iodine deficiency in New Guinea natives by iodised oil injection. Lancet 1965 II, 767–769.Google Scholar
  29. Buttfield, I. H., Hetzel, B. S.: Endemic goiter in New Guinea and the prophylactic program with iodinated poppyseed oil. In: Endemic goiter (J. B. Stanbury, ed.), chapter 11, p. 132. Washington, D.C.: WHO 1969.Google Scholar
  30. Buttfield, I. H., Pharoah, P. O. D., Hetzel, B. S.: Evidence of prevention of neurological defect in New Guinea children by iodised oil injection of mothers prior to pregnancy. Presented at the 6th International Thyroid Conference, Vienna, June 1970. Abstract No 3, p. 15.Google Scholar
  31. Carneiro, L., Dorrington, K. J., Munro, D. S.: Recovery of the long-acting thyroid stimulator from serum of patients with thyrotoxicosis by concentration of immunoglobulin G. Clin. Sci. 31, 215–221 (1966a).PubMedGoogle Scholar
  32. Carneiro, L., Dorrington, K. J., Munro, D. S.: Relation between long-acting thyroid stimulator and thyroid function in thyrotoxicosis. Lancet 1966 II, 878–880.Google Scholar
  33. Cavalieri, R. R., Searls, G. L., Rosenberg, L. L.: Studies of thyroglobulin of hypophysectomized rats. II. Nature of thyroidal iodoprotein after hypophysectomy of rats previously depleted of colloid by propylthiouracil. Endocrinology 86, 10–17 (1970).PubMedGoogle Scholar
  34. Chopra, I. J., Solomon, D. H.: Graves' disease with delayed hyperthyroidism. Ann. intern. Med. 73, 985 (1970).PubMedGoogle Scholar
  35. Chopra, I. J., Solomon, D. H., Limberg, N. P.: Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS). J. clin. Endocr. 31, 382–390 (1970).PubMedGoogle Scholar
  36. Clayton, J. A., Masuoka, D. T.: TSH-induced mobilization of serotonin from perivascular mast cells in the rat thyroid. Endocrinology 83, 263–271 (1968).PubMedGoogle Scholar
  37. Clayton, J. A., Szego, C. M.: Depletion of rat thyroid serotonin accompanied by increased blood flow as an acute response to thyroid-stimulating hormone. Endocrinology 80, 689–698 (1967).PubMedGoogle Scholar
  38. Collaço, F. M.: Bocio por dishormonogenesis. Rev. clín. esp. 108, 490 (1968).Google Scholar
  39. Conway, L. W., Schalch, D. S., Utiger, R. D., Reichlin, S.: Hormones in human pituitary sinusoid blood: Concentration of LH, GH and TSH. J. clin. Endocr. 29, 446–456 (1969).PubMedGoogle Scholar
  40. Delange, F., Thilly, C., Pourbaix, P., Ermans, A. M.: Treatment of Idjwi Island endemic goiter by iodized oil. In: Endemic goiter (J. B. Stanbury, ed.), chapter 10, p. 118. Washington, D.C.: WHO 1969.Google Scholar
  41. Dumont, J. E.: Le mécanisme d'action de l'hormone thyréotrope. Bull. Soc. Chim. biol. (Paris) 50, 2401–2426 (1968).PubMedGoogle Scholar
  42. Dumont, J. E., Ermans, A. M., Bastenie, P. A.: Thyroidal function in a goiter endemic. IV. Hypothyroidism and endemic cretinism. J. clin. Endocr. 23, 325–335 (1963).Google Scholar
  43. Dumont, J. F., Neve, P., Otten, J.: Recent advances in the knowledge of the control of thyroid growth and function. In: Endemic goiter (J. B. Stanbury, ed.), chapter 2, p. 14. Washington, D.C.: WHO 1969.Google Scholar
  44. Ekpechi, O. L.: Pathogenesis of endemic goiter in Eastern Nigeria. Brit. J. Nutr. 21, 537–545 (1967).PubMedGoogle Scholar
  45. Ensor, J. M., Munro, D. S.: A comparison of the in-vitro actions of thyroid-stimulating hormone and cyclic 3′,5′-adenosine monophosphate on the mouse thyroid gland. J. Endocr. 43, 477–485 (1969).PubMedGoogle Scholar
  46. Falconer, I. R.: The effect of vasopressin on hormone secretion and blood flow from the thyroid vein in sheep with exteriorized thyroids. J. Physiol. (Lond.) 199, 427–441 (1968).PubMedGoogle Scholar
  47. Fierro-Benitez, R., Ramirez, I., Estrella, E., Jaramillo, C., Diaz, C., Urretsa, J.: Iodized oil in the prevention of endemic goiter and associated defects in the Andean region of Ecuador. In: Endemic goiter (J. B. Stanbury, ed.), chapter 26, p. 306. Washington, D.C.: WHO 1969.Google Scholar
  48. Fierro-Benitez, R., Ramirez, I., Estrella, E., Querido, A., Stanbury, J. B.: The effect of goiter prophylaxis with iodized oil on the prevention of endemic cretinism. Presented at the 6th International Thyroid Conference, Vienna, June 1970. Abstract No 4, p. 16.Google Scholar
  49. Fleischer, N., Burgus, R., Vale, W., Dunn, T., Guillemin, R.: Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man. J. clin. Endocr. 31, 109–112 (1970).PubMedGoogle Scholar
  50. Folkers, K., Enzmann, F., Boler, J., Bowers, C. Y., Schally, A. V.: Discovery of modification of the synthetic tripeptide-sequence of the thyrotropin releasing hormone having activity. Biochem. biophys. Res. Commun. 37, 123–126 (1969).PubMedGoogle Scholar
  51. Fujita, H., Suemasa, H.: Cytological effects of TSH on the thyroid of hypophysectomized rats with and without previous administration of Actinomycin D. An electron microscope study. Arch. histol. jap. 30, 45–59 (1968).PubMedGoogle Scholar
  52. Furth, E. D., Agrawal, R. B., Propp, R. P.: Secretion of iodoalbumin and iodoprealbumin by a congenital goiter containing thyroglobulin and the iodoalbumins. J. clin. Endocr. 31, 60–69 (1970).PubMedGoogle Scholar
  53. Gaitan, E., Wahner, H. W., Cuella, C., Correa, P., Jubiz, W., Gaitan, J. E.: Endemic goiter in the Cauca Valley: II. Studies of thyroid pathophysiology. J. clin. Endocr. 29, 675–683 (1969).PubMedGoogle Scholar
  54. Gilman, A. G., Rall, T. W.: Factors influencing adenosine 3′,5′-phosphate accumulation in bovine thyroid slices. J. biol. Chem. 243, 5867–5871 (1968)a.PubMedGoogle Scholar
  55. Gilman, A. G., Rall, T. W.: The role of adenosine 3′,5′-phosphate in mediating effects of thyroid-stimulating hormone on carbohydrate metabolism of bovine thyroid slices. J. biol. Chem. 243, 5872–5881 (1968b).PubMedGoogle Scholar
  56. Greer, M. A., Grimm, Y., Studer, H.: Qualitative changes in the secretion of thyroid hormones induced by iodine deficiency. Endocrinology 83, 1193–1198 (1968).PubMedGoogle Scholar
  57. Greer, M. A., Rockie, C.: Effect of thyrotropin and the iodine content of the thyroid on the triiodothyronine: thyroxine ratio of newly synthesized iodothyronines. Endocrinology 85, 244–250 (1969).PubMedGoogle Scholar
  58. Harden, R. McG., Alexander, W. D., Papadopoulos, S., Harrison, M. T., Macfarlane, S.: The influence of the plasma inorganic iodine concentration on thyroid function in dehalogenase deficiency. Acta endocr. (Kbh.) 55, 361–368 (1967).PubMedGoogle Scholar
  59. Hart, I. R., McKenzie, J. M.: Comparison of the effects of thyrotropin and the longacting thyroid stimulator on guinea pig adipose tissue. Endocrinology 88, 26 (1971).PubMedGoogle Scholar
  60. Hennessy, W. B.: Goitre prophylaxis in New Guinea with intramuscular injections of iodized oil. Med. J. Aust. 1, 505–512 (1964).PubMedGoogle Scholar
  61. Hodge, J. V., Melmon, K. L., Sjoerdsma, A.: Hormone-induced modifications of free tyrosine in the rat thyroid gland. J. Physiol. (Lond.) 203, 1–12 (1969).PubMedGoogle Scholar
  62. Hullin, R. P., Johnson, A. W.: Effect of lithium salts on uptake of I125 by rat thyroid gland. Life Sci. 9, 9–20 (1970).PubMedGoogle Scholar
  63. Hutchison, J. H.: Familial goitrous hypothyroidism. In: Endocrine and genetic diseases of childhood (L. I. Gardner, ed.), p. 253. Philadelphia: Saunders 1969.Google Scholar
  64. Imbenotte, J., Nataf, B., Harel, J.: Action de la TSH sur la biosynthèse du RNA dans des thyroïdes de foetus de rat en culture organotypique. Bull. Soc. Chim. biol. (Paris) 51, 428–432 (1969).PubMedGoogle Scholar
  65. Jacquemin, C., Haye, B.: Controle de l'activité biologique de la thyreostimuline par la thyroxine. C. R. Soc. Biol. (Paris) 162, 1064–1069 (1968).Google Scholar
  66. Jaffiol, C., Khalil, R., Pastorello, R., Baldet, L., Mirouze, J.: Goitre sporadique tardif de l'adulte, avec déficit enzymatique en deshalogénase. Étude clinique, biochimique, isotopique. Rev. franç. Endocr. clin. 10, 67–71 (1969).PubMedGoogle Scholar
  67. Kaneko, T., Zor, U., Field, J. B.: Thyroid-stimulating hormone and prostaglandin E1 stimulation of cyclic 3′,5′-adenosine monophosphate in thyroid slices. Science 163, 1062–1063 (1969).PubMedGoogle Scholar
  68. Kerkof, P. R., Tata, J. R.: The subcellular distribution of 32P-labelled phospholipids, 32P-labelled ribonucleic acid and 125I-labelled iodoprotein in pig thyroid slices. Biochem. J. 112, 729–739 (1969).PubMedGoogle Scholar
  69. Kevany, J., Fierro-Benitez, R., Pretell, E. A., Stanbury, J. B.: Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. Amer. J. clin. Nutr. 22, 1597–1607 (1969).PubMedGoogle Scholar
  70. Kohler, P. O., Bridson, W. E., Rayford, P. L., Kohler, S. E.: Hormone production by human pituitary adenomas in culture. Metabolism 18, 782–788 (1969).PubMedGoogle Scholar
  71. Konno, N., Murthy, P. V. N., McKenzie, J. M.: Stimulation of proteolysis in the mouse thyroid gland by thyrotropin and the long-acting thyroid stimulator: Comparison of intact lobe and homogenate. Endocrinology 87, 1062 (1970).PubMedGoogle Scholar
  72. Krass, M. E., LaBella, F. S., Mailhot, R.: Bovine thyrotropin: molecular weight of the hormone derived from soluble and granular pituitary fractions, and preparation of an active fragment by enzyme hydrolysis. Endocrinology 84, 1257–1261 (1969).PubMedGoogle Scholar
  73. Krass, M. E., LaBella, F. S., Vivian, S. R.: Thyrotropin release in vitro: The role of metabolism in the secretory response to vasopressin, oxytocin and epinephrine. Endocrinology 82, 1183–1189 (1968).PubMedGoogle Scholar
  74. Kriss, J. P.: Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa and anti-lambda antisera. J. clin. Endocr. 28, 1440–1444 (1968).PubMedGoogle Scholar
  75. Kriss, J. P., Pleshakov, V., Rosenblum, A. L., Holderness, M., Sharp, G., Utiger, R.: Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J. clin. Endocr. 27, 582–593 (1967).PubMedGoogle Scholar
  76. Lee, K. L., Bowers, C. Y., Miller, O. N.: Some studies of the effect of thyroid hormone on the RNA synthesis of the anterior pituitary gland of rats. Endocrinology 83, 763–768 (1968).PubMedGoogle Scholar
  77. Levey, G. S., Roth, J., Pastan, I.: Effect of propranolol and phentolamine on canine and bovine responses to TSH. Endocrinology 84, 1009–1015 (1969).PubMedGoogle Scholar
  78. Lindsay, R. J., Cash, A. G., Hill, J. B.: TSH stimulation of orotic acid conversion to pyrimidine nucleotides and RNA in bovine thyroid. Endocrinology 84, 534–543 (1969).PubMedGoogle Scholar
  79. Lissitzky, S., Bismuth, J., Codaccioni, J.-L., Cartouzou, G.: Congenital goiter with iodoalbumin replacing thyroglobulin and defect of deiodination of iodotyrosines. Serum origin of the thyroid iodoalbumin. J. clin. Endocr. 28, 1797–1806 (1968).PubMedGoogle Scholar
  80. Lissitzky, S., Manté, S., Attali, J.-C., Cartouzou, G.: Action of 3′,5′-cyclic adenosine-monophosphate on the protein synthesizing capacity of thyroid polyribosomes in vitro. Biochem. biophys. Res. Commun. 35, 437–443 (1969).PubMedGoogle Scholar
  81. Loeb, L., Kaplan, E. E.: Studies on compensatory hypertrophy of the thyroid gland: effect of feeding anterior lobe of pituitary gland on the hypertrophy of thyroid gland in the guinea pig. J. med. Res. 44, 557–578 (1924).PubMedGoogle Scholar
  82. Maayan, M. L.: Effect of dinitrophenol on thyroid responses to thyrotropin. Endocrinology 83, 938–944 (1968).PubMedGoogle Scholar
  83. Maayan, M. L., Shapiro, R. J., Ingbar, S. H.: Metabolic functions of thyroid cell “ghosts”. Presented at the 6th International Thyroid Conference, Vienna, June 1970. Abstract No 77, p. 89.Google Scholar
  84. Macchia, V., Meldolesi, M. F., Maselli, P.: Effect of cyclic 3′,5′-AMP on glucose metabolism in thyroid homogenates. Endocrinology 85, 895–898 (1969).PubMedGoogle Scholar
  85. Macchia, V., Tamburrini, O., Pastan, I.: Role of lecithin the in mechanism of TSH action. Endocrinology 86, 787–792 (1970).PubMedGoogle Scholar
  86. Martin, J. B., Boshans, R., Reichlin, S.: Feedback regulation of TSH secretion in rats with hypothalamic lesions. Endocrinology 87, 1032 (1970).PubMedGoogle Scholar
  87. McKenzie, J. M.: Studies on the thyroid activator of hyperthyroidism. J. clin. Endocr. 21, 635–647 (1961).PubMedGoogle Scholar
  88. McKenzie, J. M.: Neonatal Graves' disease. J. clin. Endocr. 24, 660–668 (1964).PubMedGoogle Scholar
  89. McKenzie, J. M.: Humoral factors in the pathogenesis of Graves' disease. Physiol. Rev. 48, 252–310 (1968).PubMedGoogle Scholar
  90. McKenzie, J. M., Adiga, P. R., Murthy, P. V. N.: Effects of actinomycin D, cycloheximide and puromycin on thyroid stimulation. Endocrinology 83, 1132–1139 (1968).PubMedGoogle Scholar
  91. McKenzie, J. M., Gordon, J.: The origin of the long-acting thyroid stimulator. In: Current topics in thyroid research (C. Cassano and M. Andreoli, eds.). Proceedings of the 5th International Thyroid Conference, pp. 445–454. New York: Academic Press, Inc. 1965.Google Scholar
  92. McKenzie, J. M., McCullagh, E. P.: Observations against a caudal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease. J. clin. Endocr. 28, 1177–1182 (1968).PubMedGoogle Scholar
  93. Medeiros-Neto, G. A., Nicolau, W., Kieffer, J., Cintra, A. B. U.: Thyroidal iodoproteins in Pendred's syndrome. J. clin. Endocr. 28, 1205 (1968).PubMedGoogle Scholar
  94. Messier, B.: Effect of exogenous thyroxine on 3H-thyrmidine uptake in mouse pituitary gland. Acta endocr. (Kbh.) 61, 133–136 (1969).PubMedGoogle Scholar
  95. Milutinovic, P. S., Stanbury, J. B., Wicken, J. V., Jones, E. W.: Thyroid function in a family with the Pendred syndrome. J. clin. Endocr. 29, 962–969 (1969).PubMedGoogle Scholar
  96. Mittler, J. C., Redding, T. W., Schally, A. V.: Stimulation of thyrotropin (TSH) secretion by TSH-releasing factor (TRF) in organ cultures of anterior pituitary. Proc. Soc. exp. Biol. (N.Y.) 130, 406–409 (1969).PubMedGoogle Scholar
  97. Miyai, K., Fukuchi, M., Kumahara, Y., Abe, H.: LATS production by lymphocyte culture in patients with Graves' disease. J. clin. Endocr. 27, 855–860 (1967).PubMedGoogle Scholar
  98. Mouriz, J., Riesco, G., Usobiaga, P.: Thyroid proteins in a goitrous cretin with iodide organification defect. J. clin. Endocr. 29, 942–947 (1969).PubMedGoogle Scholar
  99. Murray, I. P. C., Thomson, J. A., McGirr, E. M., MacDonald, E. M., Kennedy, J. S., McLennan, I.: Unusual familial goiter associated with intrathyroidal calcification. J. clin. Endocr. 26, 1039–1049 (1966).PubMedGoogle Scholar
  100. Murray, P., Thomson, J. A., McGirr, E. M., Wallace, T. J.: Absent and defective iodotyrosine deiodination in a family some whose members are goitrous cretins. Lancet 1965 I, 183–185.Google Scholar
  101. Niall, H. D., Wellby, M. L., Hetzel, B. S., Hudson, B., Chenoweth, R. A.: Biochemical and clinical studies in familial goitre caused by an iodotyrosine deiodinase defect. Aust. Ann. Med. 17, 89–95 (1968).PubMedGoogle Scholar
  102. Ochi, Y., DeGroot, L. J.: Stimulation of RNA and phospholipid formation by long acting thyroid stimulator and by thyroid-stimulating hormone. Biochim. biophys. Acta (Amst.) 170, 198–201 (1968).PubMedGoogle Scholar
  103. Ochi, Y., DeGroot, L. J.: Effect of adenine nucleotides on thyroid hormone release in vivo and in vitro. Metabolism 18, 331–338 (1969a).PubMedGoogle Scholar
  104. Ochi, Y., DeGroot, L. J.: Stimulation of thyroid hyperplasia and protein synthesis by LATS. Endocrinology 85, 344–347 (1969b).PubMedGoogle Scholar
  105. Onaya, T., Solomon, D. H.: Effects of chlorpromazine and propranolol on in vitro thyroid activation by thyrotropin, long-acting thyroid stimulator and dibutyryl cyclic-AMP. Endocrinology 85, 1010–1017 (1969).PubMedGoogle Scholar
  106. Onaya, T., Solomon, D. H.: Stimulation by prostaglandin E1 of endocytosis and glucose oxidation in canine thyroid slices. Endocrinology 86, 423–425 (1970).PubMedGoogle Scholar
  107. Papadopoulos, S. N., Vagenakis, A. G., Moschos, A., Koutras, D. A., Matsaniotis, N., Malamos, B., Bismuth, J., Bechet, M. M., Lissitzky, S.: A case of a partial defect of the iodide trapping mechanism. J. clin. Endocr. 30, 302–307 (1970).PubMedGoogle Scholar
  108. Pastan, I., Katzen, R.: Activation of adenyl cyclase in thyroid homogenates by thyroid-stimulating hormone. Biochem. biophys. Res. Commun. 29, 792–798 (1967).PubMedGoogle Scholar
  109. Pastan, I., Roth, J., Macchia, V.: Binding of hormone to tissue: the first step in polypeptide hormone action. Proc. nat. Acad. Sci. (Wash.) 56, 1802–1809 (1966).PubMedGoogle Scholar
  110. Pastan, I., Wollman, S. H.: Colloid droplet formation in dog thyroid in vitro. J. Cell Biol. 35, 262–266 (1967).PubMedGoogle Scholar
  111. Pinchera, A., Liberti, P., Badalamenti, G.: Attività tireostimolante ad azione prolungata nel siero di conigli immunizzati con tiroide umana. Folia endocr. (Roma) 18, 522–534 (1965).Google Scholar
  112. Pretell, E. A., Moncloa, F., Salinas, R., Kawano, A., Guerra-Garcia, R., Gutierrez, L., Beteta, L., Pretell, J., Wan, M.: Prophylaxis and treatment of endemic goiter in Peru with iodized oil. J. clin. Endocr. 29, 1586–1595 (1969).PubMedGoogle Scholar
  113. Read, D. G., Hershman, J. M., Pittman, J. A.: Effect of vasopressin infusions on thyroidal radioiodine uptake and serum TSH concentration. J. clin. Endocr. 29, 1496–1498 (1969).PubMedGoogle Scholar
  114. Redding, T. W., Schally, A. V.: Studies on the thyrotropin-releasing hormone (TRH) activity in peripheral blood. Proc. Soc. exp. Biol. (N.Y.) 131, 420–425 (1969).PubMedGoogle Scholar
  115. Refetoff, S., DeWind, L. T., DeGroot, L. J.: Familial syndrome combining deafmutism, stippled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J. clin. Endocr. 27, 279–294 (1967).PubMedGoogle Scholar
  116. Riddick, F. A., Jr., Desai, K. B., Stanbury, J. B., Murison, P. J.: Familial goiter with diminished synthesis of thyroglobulin. Z. ges. exp. Med. 150, 203–212 (1969).Google Scholar
  117. Robbins, J., van Zyl, A., van der Walt, K.: Abnormal thyroglobulin in congenital goiter of cattle. Endocrinology 78, 1213–1223 (1966).PubMedGoogle Scholar
  118. Rodbell, M.: Metabolism of isolated fat cells. V. Preparation of “ghosts” and their properties; adenyl cyclase and other enzymes. J. biol. Chem. 242, 5744–5750 (1967).PubMedGoogle Scholar
  119. Rodesch, F., Neve, P., Willems, C., Dumont, J. E.: Stimulation of thyroid metabolism by thyrotropin, cyclic 3′: 5′-AMP, dibutyryl cyclic 3′: 5′-AMP and prostaglandin E1. Europ. J. Biochem. 8, 26–32 (1969).PubMedGoogle Scholar
  120. Rogowitsch, N.: Die Veränderungen der Hypophyse nach Entfernung der Schilddrüse. Beitr. path. Anat. 4, 453 (1888).Google Scholar
  121. Rosenberg, L. L., Cavalieri, R. R.: Studies of thyroglobulin of hypophysectomized rats. I. Sensitivity to the disaggregating influences of alkali and low ionic strength. Endocrinology 84, 1322–1329 (1969).PubMedGoogle Scholar
  122. Schally, A. V., Redding, T. W., Bowers, C. Y., Barrett, J. F.: Isolation and properties of porcine thyrotropin-releasing hormone. J. biol. Chem. 244, 4077–4088 (1969).PubMedGoogle Scholar
  123. Schell-Frederick, E., Dumont, J. E.: Mechanism of action of thyrotropin. In: Biochemical actions of hormones (G. Litwack, ed.), vol. 1, chapter 10, p. 415. New York: Academic Press, Inc. 1970.Google Scholar
  124. Schimmer, B. P., Ueda, K., Sato, G. H.: Site of action of adrenocorticotropic hormone (ACTH) in adrenal cell cultures. Biochem. biophys. Res. Commun. 32, 806–810 (1968).PubMedGoogle Scholar
  125. Schneider, P. B.: Effects of thyrotropin on thyroidal phospholipid and adenosine 5′-triphosphate metabolism. J. biol. Chem. 244, 4490–4493 (1969).PubMedGoogle Scholar
  126. Scott, T. W., Mills, S. C., Freinkel, N.: The mechanism of thyrotropin action in relation to lipid metabolism in thyroid tissue. Biochem. J. 109, 325–332 (1968).PubMedGoogle Scholar
  127. Shishiba, Y., Solomon, D. H., Davidson, W. D.: Comparison of the effect of thyrotropin and long-acting thyroid stimulator on glucose oxidation and endocytosis in canine thyroid slices. Endocrinology 86, 183–190 (1970).PubMedGoogle Scholar
  128. Singh, S. P., McKenzie, J. M.: Effects of thyrotropin on 35S-sulfate uptake by mouse harderian gland. Endocrinology 85, 952–955 (1969).PubMedGoogle Scholar
  129. Smith, B. R.: The interaction of the long-acting thyroid stimulator (LATS) with thyroid tissue in vitro. J. Endocr. 46, 45–54 (1970).PubMedGoogle Scholar
  130. Smith, B. R., Munro, D. S., Dorrington, K. J.: The distribution of the long-acting thyroid stimulator among γG-immunoglobulins. Biochim. biophys. Acta (Amst.) 188, 89–100 (1969).PubMedGoogle Scholar
  131. Solomon, D. H., Beall, G. N.: Thyroid-stimulating activity in the serum of immunized rabbits. II. Nature of the thyroid-stimulating material. J. clin. Endocr. 28, 1496–1502 (1968).PubMedGoogle Scholar
  132. Solomon, D. H., Beall, G. N.: Effect of thyroxine on the thyroid-stimulating activity in the serum of rabbits immunized with thyroid tissue. Endocrinology 86, 191–195 (1970).PubMedGoogle Scholar
  133. Speight, J. W., Baba, W. I., Wilson, G. M.: The effect of propylthiouracil and thyroid-stimulating hormone on the survival of rat thyroid cells in vivo and in vitro. J. Endocr. 41, 577–591 (1968).PubMedGoogle Scholar
  134. Stanbury, J. B., Rocmans, P., Buhler, U. K., Ochi, Y.: Congenital hypothyroidism with impaired thyroid response to thyrotropin. New Engl. J. Med. 279, 1132–1136 (1968).PubMedGoogle Scholar
  135. Stanbury, J. B., Wicken, J. V., Lafferty, M. A.: Preparation and properties of thyroid cell membranes. J. Membrane Biol. 1, 459–467 (1969).Google Scholar
  136. Stanbury, J. B., Wicken, J. V., Pardo, N.: Unpublished observations.Google Scholar
  137. Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S. (eds.): The Metabolic Basis of Inherited Disease. 3rd edition. McGraw-Hill, New York, 1972.Google Scholar
  138. Straznicky, K., Mess, B.: Effect of TSH on the rate of DNA and protein synthesis in embryonic chicken thyroid cells, investigated with 3H-thymidine and 3H-methionine autoradiography. Acta biol. Acad. Sci. hung. 18 (2), 221–229 (1967).PubMedGoogle Scholar
  139. Suematsu, R., Matsuda, K., Shizume, K., Nakao, K.: Thyroid response to acute reduction of circulating thyroid hormone level. Endocrinology 84, 1161–1165 (1969).PubMedGoogle Scholar
  140. Sunshine, P., Kusumoto, H., Kriss, I. P.: Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: Implications for diagnosis and therapy of the disorder. Pediatrics 36, 869–876 (1965).PubMedGoogle Scholar
  141. Taunton, O. D., Roth, J., Pastan, I.: The first step in ACTH action: Binding to tissue. J. clin. Invest. 46, 1122 (1967).Google Scholar
  142. Thomson, J. A., McGirr, E. M.: Defective deiodinase activity and abnormal thyroidal iodoproteins. J. clin. Endocr. 29, 1259–1260 (1969).PubMedGoogle Scholar
  143. Tong, W.: TSH stimulation of 14C-amino acid incorporation into protein by isolated bovine thyroid cells. Endocrinology 80, 1101–1110 (1967).PubMedGoogle Scholar
  144. Tonoue, T., Tong, W., Stolc, V.: TSH and dibutyryl-cyclic-AMP stimulation of hormone release from rat thyroid glands in vitro. Endocrinology 86, 271–277 (1970).PubMedGoogle Scholar
  145. Vale, W., Burgus, R., Dunn, T. F., Guillemin, R.: Release of TSH by oral administration of synthetic peptide derivatives with TRF activity. J. clin. Endocr. 30, 148–150 (1970).PubMedGoogle Scholar
  146. Wilber, J. F., Peake, G. T., Utiger, R. D.: Thyrotropin release in vitro: Stimulation by cyclic 3′,5′-adenosine monophosphate. Endocrinology 84, 758–760 (1969).PubMedGoogle Scholar
  147. Wilber, J. F., Porter, J. C.: Thyrotropin and growth hormone releasing activity in hypophysial portal blood. Endocrinology 87, 807–811 (1970).PubMedGoogle Scholar
  148. Wilber, J. F., Utiger, R. D.: Thyrotropin incorporation of 14C-glucosamine by the isolated rat adenohypophysis. Endocrinology 84, 1316–1321 (1969a).PubMedGoogle Scholar
  149. Wilber, J. F., Utiger, R. D.: The effect of glucocorticoids on thyrotropin secretion. J. clin. Invest. 48, 2096–2103 (1969b).PubMedGoogle Scholar
  150. Willems, C., Rodesch, F., Neve, P., Dumont, J. E.: Mechanism of action of thyrotropin through the cyclic 3′,5′-AMP system. Arch. int. Physiol. 77 (1), 179–180 (1969).PubMedGoogle Scholar
  151. Williams, J. A.: Effects of TSH on thyroid membrane properties. Endocrinology 86, 1154–1158 (1970).PubMedGoogle Scholar
  152. Williams, J. A., Wolff, J.: Thyroid secretion in vitro: Multiple actions of agents affecting secretion. Endocrinology 88, 206 (1971).PubMedGoogle Scholar
  153. Wilson, B., Raghupathy, R., Tonoue, T., Tong, W.: TSH-like actions of dibutyryl-cAMP on isolated bovine thyroid cells. Endocrinology 83, 877–884 (1968).PubMedGoogle Scholar
  154. Wolff, J.: Enzymatic properties of thyroid membranes. Presented at the 6th International Thyroid Conference, Vienna, June 1970, Abstract No 75, p. 81.Google Scholar
  155. Wolff, J., Berens, S. C., Jones, A. B.: Inhibition of thyrotropin-stimulated adenyl cyclase activity of beef thyroid membranes by low concentration of lithium ion. Biochem. biophys. Res. Commun. 39, 77–82 (1970).PubMedGoogle Scholar
  156. Wong, E. T., Litman, G. W.: Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro. J. clin. Endocr. 29, 72–78 (1969).PubMedGoogle Scholar
  157. Yamashita, K., Field, J. B.: Preparation of thyroid plasma membranes containing a TSH-responsive adenyl cyclase. Biochem. biophys. Res. Commun. 40, 171–178 (1970).PubMedGoogle Scholar
  158. Zakarija, M., Bastomsky, C. H., McKenzie, J. M.: Effect of thyrotropin on thyroid pyridine nucleotides in vivo. Endocrinology 84, 1310–1315 (1969).PubMedGoogle Scholar
  159. Zor, U., Kaneko, T., Lowe, I. P., Bloom, G., Field, J. B.: Effect of thyroid-stimulating hormone and prostaglandins on thyroid adenyl cyclase activation and cyclic adenosine 3′,5′-monophosphate. J. biol. Chem. 244, 5189–5195 (1969).PubMedGoogle Scholar
  160. Zor, U., Lowe, I. P., Bloom, G., Field, J. B.: The role of calcium (Ca++) in TSH and dibutyryl 3′5′ cyclic AMP stimulation of thyroid glucose oxidation and phospholipid synthesis. Biochem. biophys. Res. Commun. 33, 649–658 (1968).PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1972

Authors and Affiliations

  • John B. Stanbury
    • 1
  1. 1.Unit of Experimental Medicine, Department of Nutrition and Food ScienceMassachusetts Institute of TechnologyCambridge

Personalised recommendations